Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Topiramate NDC 70934-772 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 70934 772 60 Master Bottle Label Approval Rev A 06 20

Label - 70934 772 60 Master Bottle Label Approval   Rev A 06 20

The given text contains information about a medication with the NDC code 70934-772-60 called "Topiramate". It does not provide any further information about the medication.*

chemical-structure - chemical structure

chemical-structure - chemical structure

Not available.*

figure-1 - figure 1

figure-1 - figure 1

This is a graphical representation of the cumulative rates for time to the first seizure. The X-axis represents time in days, and the Y-axis shows the cumulative rate from 0.1 to 0.5. The data is divided into two groups, one taking Topiramate 50 mg/day (N=234), and the other taking Topiramate 400 mg/day (N=238). The equal (=) sign in the graph represents the point where both groups have the same seizure rate.*

figure-2 - figure 2

figure-2 - figure 2

This is a statistical table that shows the change in average monthly migraine period rate from baseline to double-blind phase for different dosages of Topiramate and placebo. The study was conducted in two parts; Study 10 and Study 11. The table shows the number of participants (N) in each group and the corresponding p-value for statistical significance.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.